CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The CardiomiR project aims to develop targeted treatments for heart failure by focusing on microRNAs involved in inflammation and metabolism. It involves collaboration between academic and industrial partners to discover and test new therapies that address these pathways.
An urgent need exists for more specific treatment options to target the metabolic changes and the related inflammatory pathways during HF.
Targeting microRNAs (miRNAs)-small RNAs implicated in protein regulation- represents a unique possibility to make novel medicines against HF.
In view of the central role of inflammatory pathways in the metabolic syndrome, they expect inflammation miRNAs to be excellent targets to treat HF.
Three partners will form a focused and natural industry-academy partn…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, Liege
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, DRESDEN
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Denmark, Horsholm
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
